Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PHENYLPIPERAZINE ARYL UREA COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
Document Type and Number:
WIPO Patent Application WO/2018/155954
Kind Code:
A1
Abstract:
The present invention relates to a compound of a particular chemical formula or a pharmaceutically acceptable salt thereof and, more specifically, to a compound capable of preventing or treating Parkinson's disease, drug abuse, schizophrenia, or a bipolar disorder, by acting as an agonist for dopamine D3 receptor, or to a pharmaceutically acceptable salt thereof.

Inventors:
CHEON SEUNG HOON (KR)
KIM KYEONG MAN (KR)
CAO YONGKAI (KR)
SHIN CHAN YOUNG (KR)
Application Number:
KR2018/002256
Publication Date:
August 30, 2018
Filing Date:
February 23, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHENZEN LINGLAN BIO PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07D241/04; A61K31/155; A61K31/4725; A61K31/496
Domestic Patent References:
WO2004099179A12004-11-18
Foreign References:
KR20070047763A2007-05-07
JPH09278737A1997-10-28
KR20170017792A2017-02-15
Other References:
DATABASE Chemical Abstract 30 April 2012 (2012-04-30), retrieved from STN Database accession no. 1371183-94-6
DATABASE Chemical Abstract 9 August 2016 (2016-08-09), retrieved from STN Database accession no. 899926-41-1
FLACHNER, B. ET AL.: "Rapid in Silico Selection of an MCHR1 Antagonists' Focused Library from Multi-million Compounds' Repositories: Biological Evaluation", MEDICINAL CHEMISTRY RESEARCH, vol. 23, no. 3, 2014, pages 1234 - 1247, XP055537088
CAPET, M. ET AL.: "Improving Selectivity of Dopamine D3 Receptor Ligands", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 26, no. 3, 2016, pages 885 - 888, XP029391922
Attorney, Agent or Firm:
DOOHO IP LAW FIRM (KR)
Download PDF: